Study of DNN.65.21.005 for enlarged prostate with urinary symptoms
Part of Kidney & urinary clinical trials.
This trial tests a new medicine (DNN.65.21.005) to see if it helps men with an enlarged prostate who have trouble urinating. It may be an option if you are 50 or older and have symptoms like needing to go often or having a weak stream.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 50 or older.
- You have symptoms like frequent urination, urgency, or a weak stream caused by an enlarged prostate.
- You have not had prostate cancer or a history of it.
- You have not used certain prostate medications recently (like alpha-blockers in the last 7 days, or finasteride/dutasteride in the last 180 days).
- You do not have Parkinson's disease or other nerve problems that affect bladder control.
- You are able to understand the study and give your permission to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, DTT106, for men who have both erectile dysfunction and an enlarged prostate (BPH). It is for men already taking dutasteride and tamsulosin and aims to see if the new treatment improves erections better.
This trial tests if combining dutasteride with aloe vera extract works better than current options to shrink the prostate and improve urine flow. If you have been diagnosed with an enlarged prostate (BPH) and are not taking certain medications, this may be a possibility for you.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
This trial tests whether a drug called adalimumab (a TNF blocker) can improve symptoms of an enlarged prostate. It is for men aged 45-80 with a large prostate and bothersome urinary symptoms who have not used this type of medication before.
This trial tests a new, once-daily tablet (H077) compared to the standard medicine silodosin for treating symptoms of an enlarged prostate. It aims to see if the new medicine works as well and is safe.
This study looks at a prostate test marker to understand who is more likely to benefit from 5-ARI medicines such as finasteride or dutasteride. If you have enlarged prostate symptoms and are getting a biopsy, the results may help doctors better choose or interpret 5-ARI treatment.
Hear when a new Prostatic Hyperplasia, Benign trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.